A Genotype-Guided Strategy for Oral P2Y [electronic resource]
Producer: 20191106Description: 1621-1631 p. digitalISSN:- 1533-4406
- Administration, Oral
- Aged
- Clopidogrel -- adverse effects
- Coronary Thrombosis -- prevention & control
- Cytochrome P-450 CYP2C19 -- genetics
- Female
- Genotype
- Hemorrhage -- chemically induced
- Humans
- Intention to Treat Analysis
- Male
- Middle Aged
- Percutaneous Coronary Intervention
- Prasugrel Hydrochloride -- adverse effects
- Precision Medicine
- Purinergic P2Y Receptor Antagonists -- adverse effects
- ST Elevation Myocardial Infarction -- drug therapy
- Single-Blind Method
- Stents
- Ticagrelor -- adverse effects
No physical items for this record
Publication Type: Equivalence Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.